/Investor DB

Catapult Ventures — 2026 Investments

5 investments dated 2026 · listed companies and verified rows first · show all

Anello Photonicsanellophotonics.cominMay 2026 · $25M✓ verified

ANELLO Photonics develops silicon photonics-based inertial navigation systems, specifically its SiPhOG platform, which delivers optical gyroscope performance in a chip-scale form factor for GPS-denied environments.

Deep TechDefense TechHardwareSemiconductorsSanta Clara, US

Dr. Mario Paniccia(Chief Executive Officer)inAvi Feshali(Founder)inMario Paniccia(Founder)Mike Horton(Founder)

Co-investorsIronGate Capital AdvisorsMana VenturesLockheed Martin VenturesHCVCIn-Q-TelMESH+2 more

Eridueridu.aiin𝕏Mar 2026✓ verified

Eridu develops networking infrastructure optimized for artificial intelligence workloads.

AI & Machine LearningCloud ComputingDeep TechHardwareSaratoga, US

Drew Perkins(Founder)inBrian Kinard(Executive Officer)in

BoardJagdeep Singh(Director)Dipender Saluja(Director)Wen Hsieh(Director)inChristian Gallagher(Director)

Co-investorsBosch VenturesMatter Venture PartnersOUP (Osage University Partners)Socratic PartnersTDK VenturesZelda Ventures+13 more

Array Labsarraylabs.ioin𝕏Series A · Jan 2026 · $20M

Array Labs develops radar technology for aerospace and other leading industries.

Advanced ManufacturingDeep TechDefense TechHardwareSpace TechSan Francisco, US

Andrew Peterson(Founder)inJose Isaac Robledo(Founder)in

Co-investorsACVC PartnersAera VCBBQ CapitalClearance Venture PartnersDellin InvestmentsGaingels+29 more

Hyfix Spatial IntelligenceinApr 2026 · $15M

Santa Clara, US

Melissa Horton(CFO)inMichael Horton(Director and CEO)Yudan Yi(Director)

Co-investorsCraft VenturesFinality Capital PartnersMulticoin Capital

Infex Therapeuticsinfextx.comin𝕏May 2026

A consortium and organization working to accelerate the development of therapeutics, vaccines, and products to combat antimicrobial resistance (AMR) through multiple innovation platforms.

BiotechDeep TechHealthtechAlderley Park, GB

Professor Janet Hemingway(iiCON Founding Director)Dr Pete Jackson(Infex Therapeutics CEO)

Co-investorsPerscitus LLP

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.